Judge approves Purdue Pharma opioid settlement
Digest more
3don MSN
Purdue Pharma’s deal means money for some victims, end of Purdue company name. Here’s what to know
OxyContin maker Purdue Pharma's efforts to settle thousands of lawsuits over the toll of opioids is on the verge of approval.
The average one-year price target for Takeda Pharmaceutical Company (OTCPK:TKPHF) has been revised to $31.95 / share. This is a decrease of 10.12% from the prior estimate of $35.55 dated September 12, ...
Regeneron is expanding its pharmaceutical production in New York, joining a wave of drug companies growing domestic ...
NetraMark Holdings Inc. (the “Company” or “NetraMark”) (CSE: AIAI) (OTCQB: AINMF) (Frankfurt: PF0), a premier artificial intelligence (AI) company transforming clinical trials with ...
The next generation of weight loss drugs will hit the market in 2026. Eli Lilly and Novo Nordisk are racing to the finish ...
(Reuters) -Several pharmaceutical companies have said they will sell drugs direct to patients in the U.S. and offered ...
9h
Medicus Pharma Ltd. Provides Corporate Updates and Reports Third Quarter 2025 Financial Highlights
Clinical development programs for doxorubicin-containing microneedle array (D-MNA) and Teverelix, a next generation GnRH antagonist, are steadily advancing PHILADELPHIA, PENNSYLVANIA / ACCESS Newswire ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results
Feedback